Pfizer

RNT Health Insights develops an AI-assisted software as a medical device (SaMD) solution for early gastric cancer detection. This technology, granted FDA Breakthrough Device Designation, improves efficiency and accuracy in real-time during endoscopic procedures, with preclinical validation showing 96% accuracy in detecting lesions indicative of gastric cancer.

Urban Health Plan, Inc. is a health center located in the Bronx, New York, serving the communities of Hunts Point, Mott Haven, and Morrisania. Established in 1974, it specializes in delivering both primary and specialty healthcare services. The organization offers a wide range of primary care options, including adolescent and adult medicine, dentistry, family planning, and pediatrics. Specialty services encompass areas such as cardiology, neurology, psychiatry, and pulmonary care, among others. Additionally, Urban Health Plan provides ancillary services like audiology, nutrition, physical therapy, and social services, as well as various diagnostic capabilities including digital radiology and laboratory testing. The center also emphasizes support services through programs focused on asthma management, diabetes care, health education, and health insurance enrollment. Furthermore, Urban Health Plan integrates telehealth services to enhance access to care for its patients.

Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.

National Eczema Association is the 501(c)(3) non-profit, US patient advocacy organization serving people affected by eczema. NEA is the driving force for an eczema community fueled by knowledge, strengthened through collective action, and propelled by the promise of a better future.

International Rescue Committee is an independent non-profit organization founded in 1933 and based in New York City. It provides emergency relief, rehabilitation, protection of human rights, post-conflict development, and resettlement services to refugees and others affected by conflict and oppression. Its work includes education, healthcare, water and sanitation, and advocacy on humanitarian and protection issues, with a focus on supporting affected communities and helping them achieve durable recovery.

PATH is an international nonprofit organization that transforms global health through innovation. It takes an entrepreneurial approach to developing and delivering high‑impact, low‑cost solutions, from lifesaving vaccines and devices to collaborative programs with communities. Through its work in more than 70 countries, PATH and its partners empower people to achieve their full potential.

CARE is a well-known international humanitarian organization. They bring about long-lasting change in some of the world's poorest areas, and they pay particular attention to assisting impoverished women because, with the right tools, they have the capacity to free whole families and entire communities from poverty.

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and conduct innovative research that contributes significantly to understanding, diagnosing, and treating cancer. NCCN programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care.

UE LifeSciences is a growth-stage FemTech company focused on preventive oncology, specializing in non-invasive breast cancer detection technologies. The company has developed a portable screening device that facilitates early-stage detection of breast cancer, thereby enabling timely treatment for patients. Its hallmark product has received regulatory clearance and has been validated through independent trials, leading to its commercial scaling across multiple markets. With a high-margin, pay-per-use revenue model, UE LifeSciences is also collaborating with major pharmaceutical companies to expand its reach into national-scale markets. The company maintains a robust product pipeline, with ongoing innovations targeting breast and cervical cancer detection, positioning it as a significant player in the healthcare technology sector.

The North Carolina Biotechnology Center, established in 1981, is a private, non-profit organization based in Durham, North Carolina. It is funded by the North Carolina General Assembly with the mission of enhancing biotechnology research, business, and education across the state. Rather than serving as a laboratory for research, the Center focuses on fostering job creation and strengthening the biotechnology sector by providing support and resources to industry stakeholders. Through its initiatives, the Center aims to generate economic and societal benefits for the region, contributing to the advancement of biotechnology in North Carolina.